中国神经再生研究(英文版) ›› 2020, Vol. 15 ›› Issue (3): 528-536.doi: 10.4103/1673-5374.266060

• 原著:脑损伤修复保护与再生 • 上一篇    下一篇

Ferrostatin-1应激保护HT-22细胞免受氧化毒性

  

  • 出版日期:2020-03-15 发布日期:2020-05-26

Ferrostatin-1 protects HT-22 cells from oxidative toxicity

Jun Chu, Chen-Xu Liu, Rui Song, Qing-Lin Li   

  1. Xin’an Key Laboratory of Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui Province, China
  • Online:2020-03-15 Published:2020-05-26
  • Contact: Qing-Lin Li, PhD,qinglin_lee@hotmail.com.

摘要:

细胞铁死亡是一种依赖于铁的细胞程序性死亡,与细胞凋亡、坏死、自噬等形式的细胞死亡不同。 细胞铁死亡可参与神经退行性疾病等多种疾病的病理过程,但是目前但是细胞铁死亡对谷氨酸诱导的神经元毒性尚不完全清楚。实验以1.25-20mM的谷氨酸干预HT-22细胞12-48h,以MTT法检测细胞存活率,确定谷氨酸干预细胞的最佳浓度和时间分别为5mM和12h。在谷氨酸干预HT-22细胞的同时以3-12μM的细胞铁死亡抑制剂Ferrostatin-1干预细胞12h,以MTT法检测细胞存活率,以试剂盒检测乳酸脱氢酶的释放,以DAPI染色检测细胞的存活,以透射电镜观察细胞的超微结构,以试剂盒检测Caspase 3的活性,以流式细胞仪定量活性氧水平,以单丹磺酰尸胺染色观察细胞自噬,以试剂盒检测Gpx活性,超氧化物歧化酶活性以及丙二醛水平,以实时PCR检测前列腺素内过氧化物合酶2和谷胱甘肽过氧化物酶4 mRNA的表达,以Western blot检测谷胱甘肽过氧化物酶4和Nrf2的蛋白表达。结果发现,(1)Ferrostatin-1干预可明显恢复谷氨酸损伤的HT-22细胞的存活率,减少乳酸脱氢酶的释放,恢复损伤的线粒体超微结构,但不影响细胞中caspase-3表达以及单丹磺酰尸胺染色情况;(2)同时降低细胞中活性氧、丙二醛水平,并增强超氧化物歧化酶活性,减少前列腺素内过氧化物合酶2mRNA的表达,增加谷胱甘肽过氧化物酶4 mRNA以及谷胱甘肽过氧化物酶4和Nrf2蛋白的表达;(3)但是,在谷氨酸干预细胞的同时,以凋亡抑制剂ZVAD-fmk(2-8μM)、自噬抑制剂3-MA(100-400μM)、坏死抑制剂Nec-1(10-40μM)、铁螯合剂去铁胺甲磺酸盐干预细胞,MTT法检测可见ZVAD-fmk、3-MA和Nec-1不影响谷氨酸诱导的细胞死亡,而去铁胺甲磺酸盐可以抑制谷氨酸诱导的HT-22细胞死亡;(4)实验证明,细胞铁死亡与谷氨酸诱导的毒性有关,而Ferrostatin-1可通过抑制氧化应激来保护HT-22细胞免受谷氨酸诱导的氧化毒性。

orcid: 0000-0002-4475-7158 (Qing-Lin Li)

关键词: 细胞铁死亡, 谷氨酸, HT-22细胞, 氧化毒性, Ferrostain-1, 谷胱甘肽过氧化物酶4, 前列腺素G/H合成酶2, 活性氧, ROS

Abstract: Ferroptosis is a type of programmed cell death dependent on iron. It is different from other forms of cell death such as apoptosis, classic necrosis and autophagy. Ferroptosis is involved in many neurodegenerative diseases. The role of ferroptosis in glutamate-induced neuronal toxicity is not fully understood. To test its toxicity, glutamate (1.25–20 mM) was applied to HT-22 cells for 12 to 48 hours. The optimal experimental conditions occurred at 12 hours after incubation with 5 mM glutamate. Cells were cultured with 3–12 μM ferrostatin-1, an inhibitor of ferroptosis, for 12 hours before exposure to glutamate. The cell viability was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Autophagy was determined by monodansylcadaverine staining and apoptosis by caspase 3 activity. Damage to cell structures was observed under light and by transmission electron microscopy. The release of lactate dehydrogenase was detected by the commercial kit. Reactive oxygen species were measured by flow cytometry. Glutathione peroxidase activity, superoxide dismutase activity and malondialdehyde level were detected by the appropriate commercial kit. Prostaglandin peroxidase synthase 2 and glutathione peroxidase 4 gene expression was detected by real-time quantitative polymerase chain reaction. Glutathione peroxidase 4 and nuclear factor erythroid-derived-like 2 protein expression was detected by western blot analysis. Results showed that ferrostatin-1 can significantly counter the effects of glutamate on HT-22 cells, improving the survival rate, reducing the release of lactate dehydrogenase and reducing the damage to mitochondrial ultrastructure. However, it did not affect the caspase-3 expression and monodansylcadaverine- positive staining in glutamate-injured HT-22 cells. Ferrostatin-1 reduced the levels of reactive oxygen species and malondialdehyde and enhanced superoxide dismutase activity. It decreased gene expression of prostaglandin peroxidase synthase 2 and increased gene expression of glutathione peroxidase 4 and protein expressions of glutathione peroxidase 4 and nuclear factor (erythroid-derived)-like 2 in glutamate- injured HT-22 cells. Treatment of cultured cells with the apoptosis inhibitor Z-Val-Ala-Asp (OMe)-fluoromethyl ketone (2–8 μM), autophagy inhibitor 3-methyladenine (100–400 μM) or necrosis inhibitor necrostatin-1 (10–40 μM) had no effect on glutamate induced cell damage. However, the iron chelator deferoxamine mesylate salt inhibited glutamate induced cell death. Thus, the results suggested that ferroptosis is caused by glutamate-induced toxicity and that ferrostatin-1 protects HT-22 cells from glutamate-induced oxidative toxicity by inhibiting the oxidative stress.

Key words: ferroptosis, ferrostatin-1, glutamate, glutathione peroxidase 4, HT-22 cell, oxidative toxicity, prostaglandin peroxidase synthase 2,
reactive oxygen species